Login / Signup

Response to Secukinumab on Synovitis using Power Doppler Ultrasound in Psoriatic Arthritis: 12-week Results from a Phase III Study, ULTIMATE.

Maria Antonietta D'AgostinoGeorg SchettAlejandra López-RdzLadislav ŠenoltKatalin FazekasRuben Burgos-VargasJose Maldonado-CoccoEsperanza NaredoPhilippe CarronAnne-Marie DugganPunit GoyankaMaarten BoersCorine Gaillez
Published in: Rheumatology (Oxford, England) (2021)
This unique ultrasound study shows that apart from improving the signs and symptoms of PsA, IL-17A inhibition with secukinumab leads to a rapid and significant reduction of synovitis in PsA patients.
Keyphrases